Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jozef Kesecioglu

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Current Opinion in Critical Care|September 5, 2025
Next-level intensive care: integrating technology and personalized treatment across the continuumJozef Kesecioglu
Critical Care Medicine|June 22, 2010
Farewell to exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome! Or, must we start all over again?Jozef Kesecioglu
Intensive Care Medicine|October 12, 2016
In memoriam: Johan GroeneveldArmand Girbes, Jozef Kesecioglu
Intensive Care Medicine|August 18, 2015
What is new in selective decontamination of the digestive tract?Jozef Kesecioglu, Philippe Eggimann
Current Opinion in Critical Care|January 6, 2006
Surfactant therapy in adults with acute lung injury/acute respiratory distress syndromeJozef Kesecioglu, Jack J Haitsma
Intensive Care Medicine|March 10, 2010
Chapter 5. Essential equipment, pharmaceuticals and supplies. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disasterCharles L Sprung, Jozef Kesecioglu,
Current Drug Targets|June 26, 2004
Is surfactant a promising additive drug in ALI/ARDS-patients?Marcus J Schultz, Jozef Kesecioglu
Intensive Care Medicine|April 29, 2021
Diversity and inclusivity: the way to multidisciplinary intensive care medicine in EuropeMaurizio Cecconi, Jozef Kesecioglu, Elie Azoulay, et al.
Intensive Care Medicine|May 13, 2025
Providing support to children during the loss of an important adult in the ICURuth Kleinpell, Bénédicte Gaillard-Le Roux, Jozef Kesecioglu
Intensive Care Medicine|January 25, 2015
Comparing intensive care units by size or levelDylan W de Lange, Hannah Wunsch, Jozef Kesecioglu
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Current Opinion in Critical Care|September 5, 2025
Next-level intensive care: integrating technology and personalized treatment across the continuumJozef Kesecioglu
Critical Care Medicine|June 22, 2010
Farewell to exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome! Or, must we start all over again?Jozef Kesecioglu
Intensive Care Medicine|October 12, 2016
In memoriam: Johan GroeneveldArmand Girbes, Jozef Kesecioglu
Intensive Care Medicine|August 18, 2015
What is new in selective decontamination of the digestive tract?Jozef Kesecioglu, Philippe Eggimann
Current Opinion in Critical Care|January 6, 2006
Surfactant therapy in adults with acute lung injury/acute respiratory distress syndromeJozef Kesecioglu, Jack J Haitsma
Intensive Care Medicine|March 10, 2010
Chapter 5. Essential equipment, pharmaceuticals and supplies. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disasterCharles L Sprung, Jozef Kesecioglu,
Current Drug Targets|June 26, 2004
Is surfactant a promising additive drug in ALI/ARDS-patients?Marcus J Schultz, Jozef Kesecioglu
Intensive Care Medicine|April 29, 2021
Diversity and inclusivity: the way to multidisciplinary intensive care medicine in EuropeMaurizio Cecconi, Jozef Kesecioglu, Elie Azoulay, et al.
Intensive Care Medicine|May 13, 2025
Providing support to children during the loss of an important adult in the ICURuth Kleinpell, Bénédicte Gaillard-Le Roux, Jozef Kesecioglu
Intensive Care Medicine|January 25, 2015
Comparing intensive care units by size or levelDylan W de Lange, Hannah Wunsch, Jozef Kesecioglu
Pageof 11